Structure, antioxidant and anti-inflammatory activities of the (4R)-and (4S)-epimers of s-carboxymethyl-l-cysteine sulfoxide
S-Carboxymethyl-L-cysteine (CMC) is an antioxidant and mucolytic commonly prescribed to patients with chronic obstructive pulmonary disease. In humans, CMC is rapidly metabolized to S-carboxymethyl-L-cysteine sulfoxide (CMCO). In this study, we assessed s
Waters, James K.,Kelley, Steven P.,Mossine, Valeri V.,Mawhinney, Thomas P.
p. 1 - 16
(2020/10/02)
Syntheses of metabolites of S-carbxymethyl-L-cysteine and S-methyl-L-cysteine and of some isotopically labelled (2H,13C) analogues
-
Meese,Specht,Hofmann
p. 957 - 965
(2007/10/02)
S-Carboxymethyl-L-cysteine (R)- and (S)-Sulfoxide
-
Meese, Claus O.
p. 473 - 474
(2007/10/02)
More Articles about upstream products of 125950-10-9